Font Size:
a
A
A
Keyword [CD19 CAR-T]
Result: 1 - 20 | Page: 1 of 2
1.
The Construction Of CD19-CAR-T Cell And The Effect Of CD19-CAR-T Cell On CD19 Positive Hematological Malignancies
2.
The Effect Of Hucmscs And Hcbmscs On T Lymphocyte Subsets
3.
The Experimental Research About The Effection Of CD19 Chimeric Antigen Receptor T-Cell With Chemotherapy Drugs
4.
The Preliminary Study Of The Novel CAR-T Function Of IL-21-CCL19
5.
Study On The Function Of αCD19-CAR-T By Silencing Of ACAT1 Gene
6.
Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
7.
Efficacy And Safety Of CD19 CAR-T Cells In Refractory/Recurrent Acute B-Lymphoblastic Leukemia:A Meta-analysis
8.
Optimization Of Gene Editing Conditions For CRISPR/Cas9 And Its Application In The Construction Of Universal CD19.CAR-T Cells
9.
Anti-tumor Effect Of Nanobody-based CD19 CAR-T Cells
10.
Changes Of Cytokine Levels After Relapsed/refractory B-ALL Treated With CD19 CAR-T Cells And Its Clinical Significance
11.
Studies On The Abilities And Safety Of Anti-CD19 Chimeric Antigen Receptor T Cells In Killing Lymphomain Vivo
12.
Efficacy And Safety Of CD19 CAR T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphocytic Leukemia With Central Nervous System Invasion
13.
Study Of T-cell Subsets In Peripheral Blood Of B-cell Acute Lymphoblastic Leukemia Patients And Their Effect On CD19 CAR-T Cell Therapy
14.
Clinical Study On Donor-derived Targeting CD19 CAR-T Cells For The Treatment Of Relapsed CD19~+ B-cell Acute Lymphoblastic Leukemia After Hematopoietic Stem Cell Transplantation
15.
Study On The Prognosis Evaluation And Treatment Strategy Of Acute Leukemia
16.
A Clinical Study Of Fourth-generation CD19-CAR T-cells In The Threapy Of Relapsed/Refractory Adult Acute B Lymphocytic Leukemia
17.
The Effect Of C-Jun Overexpression On The Function Of Cord Blood Derived CD19.CAR-T Cells
18.
Optimization Of CD19 CAR-T Based On CXCL12/CXCR4 To Enhance The Anti-tumor Effect In Lymphoma
19.
Study The Efficacy Of ITK Gene-Edited CD19 CAR T Cells On Chronic Lymphocytic Leukemia
20.
The Efficacy And Safety Study Of CD19 CAR-T Cells Immunotherapy For Relapse/Refractory Diffuse Large B-cell Lymphoma Patients—A Single Center,Single Arm,Open Clinical Study
<<First
<Prev
Next>
Last>>
Jump to